HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy
Milan J. Sonneveld(Erasmus MC), Benjamin Maasoumy(Medizinische Hochschule Hannover), Sang Hoon Ahn(Yonsei University), George Ν. Dalekos, Yasuhito Tanaka(Nagoya City University), Nicole S. Erler(Erasmus MC), Ivana Carey(King's College Hospital), Sylvia M. Brakenhoff(Erasmus MC), George Papatheodoridis(National and Kapodistrian University of Athens), Harry L.A. Janssen(Erasmus MC), Teerha Piratvisuth(Prince of Songkla University), Marı́a Buti(Vall d'Hebron Hospital Universitari), Fabien Zoulim(Université Claude Bernard Lyon 1), Man‐Fung Yuen(Queen Mary Hospital), P. Colombatto(Azienda Ospedaliera Universitaria Pisana), Kosh Agarwal(King's College Hospital), Florian van Bömmel(University Hospital Leipzig), Apichat Kaewdech(Prince of Songkla University), Heiner Wedemeyer(Medizinische Hochschule Hannover), Μargarita Papatheodoridi(National and Kapodistrian University of Athens), Maurizia Rossana Brunetto(Azienda Ospedaliera Universitaria Pisana), Thomas Berg(University Hospital Leipzig), Jun Yong Park(Yonsei University), Chien‐Hung Chen(Kaohsiung Chang Gung Memorial Hospital), Shao‐Ming Chiu(Kaohsiung Chang Gung Memorial Hospital), André Boonstra(Erasmus MC), Wai‐Kay Seto(State Key Laboratory of Synthetic Chemistry), Markus Cornberg(Erasmus MC)
Cited by 23
Related Papers
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
|New England Journal of Medicine|2014|877
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817
Hepatitis B Virus Resistance to Nucleos(t)ide Analogues
|Gastroenterology|2009|693
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
|New England Journal of Medicine|2018|605
Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region
|Gut and Liver|2016|512